Our challenge was to create a web platform that could provide a service to both patients with ulcerative colitis and to healthcare practitioners (HCPs) who specialise in the field.
UCandME platformTillotts Pharma
Tillotts Pharma is a fast-growing international pharmaceutical company located outside of Basel in Switzerland. The company produces innovative pharmaceutical products, medical devices, and diagnostics in the field of gastroenterology. Our challenge was to create a web platform that could provide a service to both patients with ulcerative colitis and to healthcare practitioners (HCPs) who specialise in the field.
We completed a concept research phase to provide Tillotts with an objective view of the patient and HCP journey. Within the programme team, we worked with market research companies and consultant clinicians to ensure a full and collective understanding of the requirements. A concept was developed that would allow patients to provide information anonymously through a modern, easy to use digital interface. This has allowed patients to make use of the tool in a variety of scenarios and on many different platforms.
Within the application, both the patient and the HCP have distinct user journeys. Each journey has been specifically designed to offer relevant content and functionality. As part of the project process, we produced many designs and iterations of the application. This allowed for multiple feedback sessions to incorporate feedback from both internal Tillotts stakeholders and HCPs. We created a prototype application to allow demonstration of the depth of functionality prior to the development stages. The final application was developed using the Drupal content management system. The Drupal system allows for content editors to easily create new content and edit existing pages. The application has been specifically tailored to offer a multi-language, multi-regional approach.